BOSTON, Jan. 28, 2022 /PRNewswire/ NeuroBo Pharmaceuticals, Inc. , a clinical-stage biotechnology company, today announced the appointment of D. Gordon Strickland to its Board of Directors,. | January 28, 2022
Operator
Good day, ladies and gentlemen and thank you for standing by. Welcome to the First Industrial First Quarter 2021 Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded. [Operator Instructions] At this time, I would like to turn the conference over to Mr. Art Harmon. Thank you. Sir, please begin.
Arthur Harmon
Vice President, Investor Relations & Marketing
Thank you, Howard. Hello, everybody, and welcome to our call. Before we discuss our first quarter 2021 results as well as updated guidance, let me remind everyone that our call may include forward-looking statements as defined by federal securities laws. These statements are based on management s expectations plans and estimates of our prospects. Today s statements may be time sensitive and accurate only as of today s date, Thursday, April 22, 2021. We assume no obligation to update our statements or the other information we provide. Actual results may differ materially
RALEIGH Telehealth company CarePICS, which uses a technology-enabled virtual care platform to improve patient outcomes for those suffering from peripheral artery disease (PAD), completed an agreement this week to sell a minority state in the five-year-old, Raleigh-based company to Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII).
The partnership deal also includes an acquisition option agreement.
“CarePICS is the connective tissue between collaborating physicians and their patients,” said CarePICS CEO Paul E. Schubert, in a statement. “Our platform provides effective multidisciplinary case management before and after vascular treatment. It produces a clear wound healing outcomes data set for all physicians involved throughout a patient’s care.”